Elicio Therapeutics awards 21,750 options to director
Elicio Therapeutics granted director Julian Adams a 21,750-share stock option as his 2026 annual non-employee director equity award.
Rhea-AI Filing Summary
Elicio Therapeutics, Inc. (ELTX) reported that director Julian Adams received a stock option grant for 21,750 shares of common stock on August 31, 2026. The option has an exercise price of $2.70 per share and expires on August 31, 2036.
The award is the annual non-employee director equity grant and will vest in full on the earlier of August 31, 2027 or the 2027 annual stockholders’ meeting, subject to his continued service. No additional equity award will be made to him in connection with the 2026 annual meeting of stockholders. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 21,750 shares
Grant/Award
1 txn
Insider
ADAMS JULIAN
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 21,750 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,750 contracts (Direct)
Footnotes (1)
- F1. The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Key Figures
Stock options granted: 21,750 options
Exercise price: $2.70 per share
Expiration date: August 31, 2036
+2 more
5 metrics
Stock options granted
21,750 options
Annual non-employee director equity award granted August 31, 2026
Exercise price
$2.70 per share
Exercise price of stock options granted to Julian Adams
Expiration date
August 31, 2036
Expiration of stock options granted August 31, 2026
Shares underlying options
21,750 shares
Common stock underlying the stock option grant
Shares held in option after transaction
21,750 options
Total derivative securities held directly by Julian Adams after this grant
Key Terms
Stock Option, exercise price, vesting, non-employee director equity award
4 terms
Stock Option financial
"The stock option represents the annual non-employee director equity award"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion or exercise price of the option is $2.7000 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shall vest and become exercisable in full on the earlier of (A) August 31, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
non-employee director equity award financial
"represents the annual non-employee director equity award to the Reporting Person"
FAQ
What equity award did Elicio Therapeutics (ELTX) grant to director Julian Adams?
Elicio Therapeutics granted Julian Adams a stock option for 21,750 shares of common stock on August 31, 2026 as his annual non-employee director equity award.
What is the exercise price of Julian Adams’ new ELTX stock options?
The stock options granted to Julian Adams have an exercise price of $2.70 per share, allowing him to buy Elicio Therapeutics common stock at that price once the options vest and become exercisable.
When do Julian Adams’ ELTX stock options vest and become exercisable?
The options will vest and become exercisable in full on the earlier of August 31, 2027 or the 2027 annual meeting of stockholders, provided he continues to provide services to Elicio Therapeutics through that vesting date.
When do Julian Adams’ ELTX stock options expire?
The stock options granted to Julian Adams expire on August 31, 2036, giving him a 10-year term from the August 31, 2026 grant date to exercise vested options.
Will Julian Adams receive another ELTX equity award for the 2026 annual meeting?
No. The filing states that no additional equity award will be made to Julian Adams in connection with the 2026 annual meeting of stockholders; this grant represents his annual non-employee director equity award.
Were Julian Adams’ ELTX transactions made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates no Rule 10b5-1 trading plan for this transaction, meaning the grant is reported as a standard equity award rather than under a pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
